Syngen Biotech Co.,Ltd. (TPEX:8279)
Taiwan
· Delayed Price · Currency is TWD 133.00
-1.00 (-0.75%)
Jun 13, 2025, 1:30 PM CST
Syngen Biotech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 12, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 3,604 | 3,442 | 4,119 | 4,390 | 3,062 | 2,927 | Upgrade
|
| Market Cap Growth | -21.27% | -16.45% | -6.17% | 43.36% | 4.63% | -8.09% | Upgrade
|
| Enterprise Value | 3,627 | 3,630 | 4,390 | 4,817 | 3,106 | 2,887 | Upgrade
|
| Last Close Price | 133.00 | 127.00 | 147.25 | 152.43 | 103.01 | 94.65 | Upgrade
|
| PE Ratio | 14.94 | 14.33 | 14.99 | 13.67 | 12.88 | 13.58 | Upgrade
|
| Forward PE | - | 13.20 | 13.20 | 13.20 | 13.20 | 13.20 | Upgrade
|
| PS Ratio | 1.77 | 1.71 | 2.24 | 2.27 | 2.08 | 2.23 | Upgrade
|
| PB Ratio | 1.67 | 1.54 | 1.93 | 2.20 | 1.73 | 1.80 | Upgrade
|
| P/TBV Ratio | 1.69 | 1.56 | 1.96 | 2.23 | 1.75 | 1.83 | Upgrade
|
| P/FCF Ratio | 11.61 | 11.96 | 12.74 | - | 11.14 | - | Upgrade
|
| P/OCF Ratio | 9.79 | 9.89 | 9.92 | 15.82 | 9.10 | 13.29 | Upgrade
|
| EV/Sales Ratio | 1.79 | 1.80 | 2.39 | 2.50 | 2.11 | 2.20 | Upgrade
|
| EV/EBITDA Ratio | 8.58 | 9.03 | 11.37 | 11.13 | 8.93 | 8.97 | Upgrade
|
| EV/EBIT Ratio | 11.94 | 11.97 | 14.50 | 13.29 | 11.03 | 11.14 | Upgrade
|
| EV/FCF Ratio | 11.68 | 12.61 | 13.58 | - | 11.30 | - | Upgrade
|
| Debt / Equity Ratio | 0.16 | 0.18 | 0.25 | 0.30 | 0.13 | 0.15 | Upgrade
|
| Debt / EBITDA Ratio | 0.80 | 0.95 | 1.34 | 1.34 | 0.65 | 0.75 | Upgrade
|
| Debt / FCF Ratio | 1.09 | 1.38 | 1.67 | - | 0.86 | - | Upgrade
|
| Asset Turnover | 0.65 | 0.65 | 0.60 | 0.70 | 0.65 | 0.65 | Upgrade
|
| Inventory Turnover | 3.70 | 3.71 | 3.32 | 3.76 | 3.42 | 3.36 | Upgrade
|
| Quick Ratio | 1.07 | 1.47 | 1.29 | 1.00 | 1.68 | 2.32 | Upgrade
|
| Current Ratio | 1.63 | 2.22 | 1.94 | 1.55 | 2.43 | 3.26 | Upgrade
|
| Return on Equity (ROE) | 11.46% | 11.00% | 13.33% | 17.07% | 14.00% | 13.83% | Upgrade
|
| Return on Assets (ROA) | 6.14% | 6.12% | 6.13% | 8.26% | 7.75% | 7.99% | Upgrade
|
| Return on Capital (ROIC) | 7.53% | 7.15% | 7.19% | 9.85% | 9.06% | 9.20% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.90% | 11.80% | 12.00% | 15.40% | 14.10% | 14.30% | Upgrade
|
| Earnings Yield | 6.70% | 6.98% | 6.67% | 7.32% | 7.76% | 7.36% | Upgrade
|
| FCF Yield | 8.61% | 8.36% | 7.85% | -6.99% | 8.97% | -1.80% | Upgrade
|
| Dividend Yield | 3.73% | 3.94% | 3.40% | 3.28% | 3.88% | 3.70% | Upgrade
|
| Payout Ratio | 56.09% | 56.41% | 49.30% | 33.75% | 39.89% | 37.72% | Upgrade
|
| Buyback Yield / Dilution | -0.01% | - | 0.01% | 0.00% | 0.01% | -12.85% | Upgrade
|
| Total Shareholder Return | 3.73% | 3.94% | 3.41% | 3.28% | 3.89% | -9.15% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.